<http://schema.org/description>
"Bristol-Myers Squibb is a company in transition, with a host of new products under regulatory review or in clinical development. Here are three reasons why the company may falter in its plan to move past the patent cliff. "^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fool.com/investing/general/2014/09/04/3-reasons-bristol-myers-squibbs-stock-could-fall.aspx>